Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Esters of estrogenic compounds from Lilly

April 16, 1997

Norian seeks FDA approval for orthopedic applications of Norian SRS

April 15, 1997

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

April 15, 1997

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Pharmacia & Upjohn introduces new GH delivery device

April 14, 1997

Orally active GH secretagogues reported by Lilly

April 14, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...